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Available online 17 November 2015Escherichia coliO157:H7 is an enterohemorrhagic E. coli (EHEC) strain and amajor food-borne pathogen, causing
severe disease in humans worldwide. Multiple sensitive, accurate, and quantitative methods are needed to pro-
vide a comprehensive analysis of cell damage caused by O157:H7. However, the current, universally adopted
methods for O157:H7 virulence assessment fail to investigate the interactive effects of O157:H7 and its host
cells, neglect the effects of infection of host cells by O157:H7, and fail to comprehensively and accurately reﬂect
the true pathogenicity of O157:H7. In this study, three different accurate, sensitive, and quantiﬁable methods
were supplementary to provide standard operating procedures to analyze the cytotoxicity of O157:H7. This set
of methods can be applied to toxicity studies of newly discovered O157:H7 clinical isolates and used to study
how a clinical isolate's toxicity correlateswith its pathogenicity. Thesemethods can also be used in future studies
of latent virulence factors and to explore the pathogenic mechanisms of O157:H7.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Cytotoxicity1. Introduction
Since 1982, when the ﬁrst Escherichia coli O157:H7-induced food
poisoning outbreak occurred in the U.S., O157:H7 epidemics have grad-
ually proliferated and spread in many areas around the world (Beltz,
2011; Lynch et al., 2006). In China, reported cases of O157:H7 infections
occur each year. In 1999, a particularly severe O157:H7 infectious diar-
rheal epidemic occurred in Jiangsu and other areas, with as many as
20,000 affected patients.
E. coli O157:H7 is an enterohemorrhagic E. coli (EHEC) strain and a
major food-borne pathogen, causing severe diseases in humans world-
wide. O157:H7 infections result mainly from the ingestion of contami-
nated food or water or from oral contact with contaminated surfaces
(Mead and Grifﬁn, 1998). The toxicity of O157:H7 is very high
(Kauffman and LeJeune, 2011), and the minimum infectious dose is
less than 10pathogenic bacteria (Garg et al., 2008).Moreover, this path-
ogenmay be highly lethal. The O157:H7 strain infectionmay be asymp-
tomatic, or it may induce clinical symptoms including mild diarrhea,enhp0909@163.com (H. Chen).
rk.
. This is an open access article underhemorrhagic enteritis, hemolytic–uremic syndrome sace (Niles et al.,
2007), and thrombotic thrombocytopenic purpura (TTP) (Byelashov
et al., 2010). Antibiotic treatment can lead to aggravation of the
O157:H7 infection (Bielaszewska et al., 2011), but the exact etiology
of this phenomenon remains unclear. Currently, there are no efﬁcacious
treatments for O157:H7 infection.
TheO157:H7 genomeharbors threemajor virulence loci, namely the
locus of enterocyte effacement (LEE) pathogenicity island (Wong et al.,
2011), the Shiga toxin (Stx) prophage, and the F-like plasmid pO157
(Perna et al., 2001; Hayashi et al., 2001). The LEE pathogenicity island
encodes a type III secretion system that is able to secrete effector pro-
teins out of bacterial cells and deliver them into host cells, which not
only induces the attaching and effacing lesions but also subverts multi-
ple host cell signaling pathways during infection. The Stx prophage en-
codes Stx1 and Stx2, which are antigenically distinct toxinswith similar
biological activities of cell damage (Strockbine et al., 1986). The pO157
plasmid encodes a number of virulence factors, including the
enterohemolysin EhxA, the secreted serine protease EspP, the cata-
lase–peroxidase KatP, the adhesin ToxB, the Cl esterase inhibitor StcE,
and the type II secretion system (Lim et al., 2010). Nevertheless, the de-
tailed roles of these virulence factors in the pathogenicity of O157:H7
are largely unknown, and there may be additional, uncharacterized vir-
ulence factors.the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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three virulence loci, are involved in the bacterial toxicity against host
cells (Moxley, 2004; Wang et al., 2011; Dziva et al., 2007), which is a
major component of O157:H7 pathogenicity. Analyzing bacterial cyto-
toxicity is clearly important for the virulence assessment of O157:H7.
The pathogenicity of O157:H7 is closely related to its toxicity to host
cells, and the level of O157:H7 toxicity depends on the strength of the
effects of its virulence factors. The interaction between the organism's
virulence factors and the cellular target site forms the molecular basis
for O157:H7 infection and pathogenicity.
After O157:H7 infects the epithelial cells of the host digestive
system, it induces cytotoxicity by interacting with the intestinal
epithelial cells (Bielaszewska et al., 2011). The virulence associated
with this interaction is used to determine the level of toxicity
(Moxley, 2004).
At present, functional studies of the known O157:H7 virulence
factors are insufﬁcient. Efforts to understand themechanisms of interac-
tion between the virulence factors and the host remain unsystematic.
Furthermore, the pathogenicmechanismof O157:H7has not been com-
prehensively clariﬁed. As a result, the virulence assessment is very im-
portant for analyzing the cytotoxicity of O157:H7. Virulence involves
quantitative concepts. To analyze the cytotoxicity of O157:H7, it is nec-
essary to employ quantiﬁable virulence assessmentmethods with a de-
ﬁned sensitivity. The virulence of O157:H7 for host cells is composed of
many factors. The O157:H7 chromosome encodes at least 131 proteins
assumed to have virulence-related functions that are not present in
the K-12 strain (Shabanova et al., 2009). The superposition of effects
of the various O157:H7 virulence factors on the host cells determines
the level of virulence. Therefore, investigating only one or a few of the
existing virulence factors of O157:H7 and their effects may not reﬂect
the actual toxicity of O157:H7.
Currently, the widely adopted methods for virulence assessment of
O157:H7 primarily include gene detection (Hayashi et al., 2001) (poly-
merase chain reaction (Lebeis et al., 2008) and blotting techniques),
Shiga-like toxin (SLT) detection (Bonetta et al., 2011), and testing for at-
tachment and effacing damage (A/E damage) (Badouei et al., 2010). The
genetic analysis of a sample can only provide information on gene se-
quences; it cannot demonstrate virulence factor expression. SLT detec-
tion only investigates the cytotoxicity effects of some virulence factors
of O157:H7; it does not reﬂect the full toxicity of O157:H7. Testing for
A/E damage mainly focuses on analyzing the interaction between
O157:H7 and the host cell skeletal molecule F-actin, neither providing
an accurate quantiﬁcation of the damage nor assessing the full cytotox-
icity effects of O157:H7 infection. Finally, the methods used to investi-
gate the intrinsic traits of O157:H7 (serological methods, cell culture,
and biochemical reactions (Lebeis et al., 2008; Bonetta et al., 2011)) can-
not reﬂect the true virulence of O157:H7 because O157:H7 expresses its
full virulence only after coming into contact with the host cells and
activating the corresponding signaling pathway. For example, the
type III secretory system is closely associated with pathogenicity
(Bonyadian et al., 2010). However, this system can only be activated
after O157:H7 contacts the host cells. In short, the current, universally
adopted methods for O157:H7 virulence assessment neglect the direct
infection of host cells byO157:H7 and their effects such as infection trig-
gers, fail to investigate the interactive effects of O157:H7 and the host
cells, and fail to comprehensively and accurately reﬂect the true patho-
genicity of O157:H7.
The composition of O157:H7 virulence factors is complex and still not
fully understood, and the consolidated results obtained from employing
different analytical methods allow a more comprehensive understand-
ing of the virulence of O157:H7. Therefore, a comprehensive analysis of
the effect of cell damage caused by O157:H7 is necessary. The objective
of our study is to ﬁnd some more sensitive, accurate, and quantiﬁable
methods for the systematic virulence assessment of O157:H7 and tech-
niques for pathogenicity analysis. In this study, we found three different
methods, ﬂow cytometry and cell vitality and LDH release analyses andﬂuorescence detection,whichwere supplementary to yield standard op-
erating procedures for the analysis of cytotoxicity in O157:H7.
2. Materials and methods
2.1. Bacterial isolates and culture
The E. coli O157:H7 strain EDL933 (stx1-, stx2-, eaeA-, ehxA-, tccp-
and espA-positive) was originally isolated from a patient with diarrhea
(Riley et al., 1983) and was kindly provided by Prof. Long Liang (Insti-
tute of Biotechnology, Beijing). A CT-Sorbitol MacConkey agar plate
(CT-SMAC) was used as a selective medium for the isolation and differ-
entiation of O157:H7. The K-12 strain E. coli MG1655, a human com-
mensal strain, was obtained from ATCC. The original E. coli strain K-12
was obtained from a stool sample of a diphtheria patient in Palo Alto,
CA in 1922 (Neidhardt and Curtiss, 1996).
Bacterial cultures were propagated in Luria-Bertani agar or grown
aerobically with constant shaking (200 rpm) in Luria-Bertani broth at
37 °C. The number of E. coli O157:H7 or K-12 cells was determined by
the drop-plate method. Brieﬂy, 0.1 ml of each sample was spread onto
three Luria-Bertani agar plates, which were then incubated at 37 °C
for 15 h.
2.2. Cell culture
Cells of thehumanepithelial cell lines HeLa andHT-29were cultured
in DMEM (Dulbecco'sModiﬁed EagleMedium) and RPMI (Roswell Park
Memorial Institute) 1640 media, respectively, with the addition of 10%
fetal bovine serum (FBS). The cells were incubated at 37 °C in 5% CO2
in a humidiﬁed incubator. Cells were plated 18 to 24 h prior to infection
so that the cell density reached 90% conﬂuency at the time of infection.
For ﬂuorescence microscopy, cells were grown on coverslips.
2.3. Infection conditions
O157:H7 and K-12 were grown overnight with constant shaking
(200 rpm) at 37 °C in Luria-Bertani broth. Then, they were diluted
with freshbroth and cultureduntil themid-logarithmic phase of growth
(OD600 = 0.3). Bacteria were harvested, washed with phosphate buff-
ered saline (PBS), resuspended in fresh cell culture medium with 5%
FBS and adjusted to the appropriate density.
2.4. Flow cytometry assay
The supernatants of the infected cultures were removed to preserve
the detached cells. Subsequently, the adherent cells were harvested by
standard trypsin treatment and combinedwith the cells from the super-
natants. Cell samples were washed once with PBS and submitted to
analysis by ﬂow cytometry. Cell apoptosis was analyzed using the PE
Annexin V Apoptosis Detection Kit I(BD, USA). Uninfected cells served
as a negative control to set the threshold marker for the discrimination
of ﬂuorescein isothiocyanate (FITC)-negative and -positive cells. Ac-
cording to the manufacturer's instructions, cells that are considered vi-
able are PE Annexin V and 7-Amino-Actinomycin (7-AAD) negative;
cells that are in early apoptosis are PE Annexin V positive and 7-AAD
negative; and cells that are in late apoptosis or already dead are both
PE Annexin V and 7-AAD positive.
2.5. Lactate dehydrogenase (LDH) assay
After infection with O157:H7 or K-12, LDH was assayed using a
Cytotox 96 Non-Radioactive Cytotoxicity Assay kit (Promega, Madison,
WI, USA). Fifty microliters of the supernatant from each culture were
transferred to a 96-well plate. For maximum LDH release, cell lysis solu-
tion was added to each well, followed by 50 μl of the reconstituted sub-
stratemix. After stopping the reaction, the absorbancewasmeasured at
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Untreated cells were lysed with 10 μl of 10% Triton-X100 in water
(Millipore) as a positive control. The proportion of dead cells in each
well (cytotoxicity)was calculated as [(experimental− target spontane-
ous) / (target maximum− target spontaneous)] × 100.
2.6. CellTiter-ﬂuor™ cell viability assay
Cell viability was analyzed using CellTiter-Fluor cell viability assays
(Promega, Madison, WI, USA). HeLa and HT-29 cells were seeded in
96-well culture plates, and following overnight incubation, the cells
were infected with O157:H7 and K-12 at deﬁned multiplicity of infec-
tion (Garg et al., 2008) ratios. CellTiter-Fluor reagentwas added tomea-
sure cell viability after 6 h post-infection, and the absorbance at 490 nm
determined following 30 min of incubation using plate reader (Versa
max, Molecular Devices) according to the manufacturer's instructions.
Themean of six experimental replicates from three independent exper-
imentswas determined. Untreated HeLa andHT-29 cells served as vehi-
cle control. Cell viabilities were calculated as percentages of the vehicle
control. Statistical analysis was carried out using Student's t-test.
2.7. Fluorescence detection
HeLa cells infected with O157:H7 (MOI = 800:1) and K-12 (MOI =
800:1) were seeded onto sterile coverslips, washed with PBS, and ﬁxed
in 4% paraformaldehyde (PFA) for 20 min at room temperature (RT).
After washing and permeabilizing the cells with 0.2% Triton X-100 for
10 min at RT, cells were incubated with TRITC-conjugated phalloidin
(Millipore, Billerica, USA) for 30 min at RT and stained with 0.2% DAPI
solution, with washes between each step. The cells were examined
using a Nikon Eclipse TE2000-U ﬂuorescence microscope.
2.8. Statistical analysis
The signiﬁcance of variability between themeans of the experimen-
tal groups was analyzed by Student's t-test with the Satterthwaite ap-
proximation.
t0 ¼ X1−X2ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
S21
n1
þ S
2
2
n2
s v ¼ S2X1 þ S2X2
 2
S4X1
n1−1
þ
S4X2
n2−1
All data are presented as mean ± SD. Two paired Student's t-test
was performed to determine signiﬁcance at p b 0.05(*), p b 0.01(**),
p b 0.001(***).
3. Results
To assess the cytotoxicity of O157:H7, E. coli strain K-12 (a non-EHEC
strain) was selected as the control. We investigated cytomorphology,
adhesion, apoptosis, cell viability, and the enzymatic activity of living
epithelial cells post-infection, as well as the cytotoxicity of O157:H7 to
epithelial cells with respect to cell membrane integrity.
3.1. Cellular apoptosis assays by ﬂow cytometry
To investigate the cytotoxicity effects of O157:H7more comprehen-
sively, we ﬁrst used cellular apoptosis assays to monitor host cell apo-
ptosis in a time-dependent manner. Flow cytometry is important for
measuring cellular apoptosis. In this study, we used ﬂow cytometry to
analyze the difference in the progress of cellular apoptosis after HeLa
cells were infected with O157:H7 and K-12, respectively.
HeLa cells were infected with O157:H7 or K-12, with a MOI of 800:1
(Garg et al., 2008). After 2 h to 7 h post-infection, cells were harvestedand labeled with ﬂuorescein isothiocyanate (FITC) as described previ-
ously. As shown in Fig. 1, most cells began to show apoptosis at 3 h
post-infectionwith O157:H7. The number of apoptotic cells was rapidly
increasing at 4 h post-infection with O157:H7. Together, these results
indicate that O157:H7 caused more serious injury to the cells than did
K-12, and there was a pronounced difference in cytotoxicity between
O157:H7 andK-12. Theseﬁndings demonstrate that this assay can accu-
rately reveal differences in the cytotoxicity of different strains.
3.2. Cell viability assay and LDH assay
After host cells were infected with O157:H7, the cell membrane
structure was damaged through multiple virulence factors, causing an
overall increase in the permeability of the cell membrane and the re-
lease of cytosolic contents. Therefore, we measured the intracellular
constituents to assess cell membrane integrity and permeability.
Our ﬁrst protocol measured the intracellular molecules that serve as
viabilitymarkers. Here, we investigated the change in the distribution of
enzymatic activity within the cells. As a living cell marker, the live-cell
protease is only active in cells that have a healthy cell membrane
(Niles et al., 2007), indicating cell viability. This assay is a widely
adopted standard method for measuring cell membrane integrity. The
integrity of the cell membrane can be determined through intracellular
changes in enzymatic activity.
We measured the intracellular enzymatic activity after infection
with O157:H7 (MOI = 16:1) or K-12 (MOI = 16:1). As shown in
Fig. 2, O157:H7 causedmore serious cell damage than K-12. In addition,
lower cell viability was observed post-infection with either O157:H7 or
K-12; however, at corresponding time points, the activity of HeLa cells
infected with O157:H7was lower than that infected with K-12. Similar-
ly, the activity of HT-29 cells infectedwith O157:H7was lower than that
of cells infected with K-12 at the same time point. O157:H7 had an ob-
vious inﬂuence on the viability of HeLa and HT-29 cells; this result indi-
cates that the cytotoxicity of O157:H7 can be quantitatively measured.
The cell viability assay can accurately reveal the different cytotoxicity
levels of different strains. Whereas after infected with O157:H7 or K-
12, the differences of HT-29 cell variability were more obvious than
the viability of HeLa. At 4.5 h and 6 h post-infection of O157:H7 or K-
12, the viability of HeLa had no signiﬁcant difference, while the viability
of HT-29 had signiﬁcant difference. We can conclude that HT-29 cell
could be used more sensitively to differentiate the differences of viru-
lence between different bacterial strains by this method.
As a supplement to the method described above, we considered it
important to detect not only the residual amounts of critical molecules
after host cell infectionwith the bacteria but also the release of intracel-
lular material. LDH is a stable cytoplasmic enzyme present in all cells. It
is rapidly released into the cell culture supernatant when the plasma
membrane is damaged.
To determine the cytotoxicity effect of O157:H7 in epithelial and in-
testinal cells, we measured the level of LDH in the supernatants post-
infection. The level of LDH increased signiﬁcantly with the time-
dependent and MOI dose-dependent increase in cytotoxicity in
O157:H7-infected HeLa cells compared with the level of LDH in K-12-
infected cells (Fig. 3A and C). Furthermore, these resultswere replicated
in the LDH analyses of infected HT-29 cells (Fig. 3B and D).
As shown in Fig. 3, we analyzed the cytotoxicity of different doses of
bacteria to HeLa andHT-29 cells at 3 h post-infectionwith O157:H7 and
K-12, andwe also analyzed the cytotoxicity of O157:H7 and K-12 under
a ﬁxed infectious dose (MOI = 16:1) to HeLa and HT-29 cells. With in-
creasing dose, the toxicity of bothO157:H7 and K-12 toHeLa andHT-29
cells increased (Fig. 3A and B); however, at the same dose, the cytotox-
icity of O157:H7was stronger than that of K-12 to both HeLa and HT-29
cells, indicating that the different bacteria had different levels of cyto-
toxicity to HeLa and HT-29 cells. Thus, the virulence of the different
strains of O157:H7 can be assessed by this method. Meanwhile, at the
ﬁxed dose (MOI = 16:1) (Fig. 3C and D), the cytotoxicity of O157:H7
Fig. 1. Flow cytometry assay of apoptosis of epithelial cells after infectionwith K-12, a non-EHEC strain, orO157:H7. HeLa cellswere infectedwith O157:H7 and K-12 at aMOI of 800:1. The
infected cells were harvested and labeled with FITC, and the percentages of FITC-positive cells were determined by ﬂow cytometry at 2 h, 3 h, 4 h, 5 h, 6 h, and 7 h post-infection.
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single time point, the two strains had different cytotoxicity levels;
this procedure may therefore be used to quantify the cytotoxicity
of different strains of O157:H7. Meanwhile we noticed that, in Fig.
3A, between the variability of HeLa cell assays, the point where
16:1 MOI is used for 3 hours there had no signiﬁcant difference.
However, in panel C, using 16:1 MOI between 2 and 4 h, there is
N50% difference (indicated to be signiﬁcant). Compared with HT-
29 cells, Hela cells were not very sensitive, and the results were un-
stable, so HT-29 cells were more appropriate as detecting cells by
this method.3.3. Fluorescence
Bacteria effect protein, EspFu, can induce the formation of actin ped-
estals, which is needed by bacteria adhesion. Bacteria adhesion is relat-
ed to bacteria infectivity, which is a part of the cytotoxicity of bacteria.
So through detecting the formation of actin pedestals, the cytotoxicity
of E. coli O157:H7 can be observed. After the host cells were infected
with O157:H7, the cytomorphology of the cells changed. As shown in
Fig. 4, ﬂuorescence was used to observe the host cells after bacterial in-
fection and to monitor changes in the distributions of the cytoskeleton
molecule actin and Vinculin. The ﬁgure shows the distribution of
Fig. 2. Time-dependent effects on cell viability of HeLa cells (A) and HT-29 cells (B) after infectionwith E. coliO157:H7 (MOI= 16:1) and K-12 (MOI= 16:1). From 3–7.5 h post-infection,
the viability of HeLa cells infectedwith O157:H7 decreased faster than infectedHT-29 cells. The viability of HeLa cells infectedwithO157:H7was lower than that of cells infectedwith K-12
in HeLa and HT-29 cells at corresponding time points (*, p b 0.05; **, p b 0.01; ***, p b 0.001).
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K-12, respectively. Red ﬂuorescence on themembranes of HeLa cells in-
dicates the distribution of actin. Brighter areas of red ﬂuorescence on
the cell membrane represent more concentrated areas of actin. In addi-
tion, green ﬂuorescence on the membranes of HeLa cells indicates Vin-
culin. The molecular conﬁguration of the cytoskeleton actin on the cell
membrane underwent a signiﬁcant change post-infection. However, in-
fection with O157:H7 produced a more signiﬁcant change in cytoskele-
tal structure than did infection with K-12. This result demonstrates the
characteristic cytological effects of O157:H7 and shows that monitoring
changes in cytoskeletal structure can be used to assess the cytological
effects of O157:H7.Fig. 3.Dose- and time-dependent effect of cell cytotoxicity of E. coliO157:H7 and K-12. HeLa and
the cytotoxicity to HeLa and HT-29 cells infected by O157:H7 or K-12 at various doses (MOI= 1
the increase in infectious doses of O157:H7 and K-12 (A and B). Toxicity of O157:H7 and K-12 to
12, and after the ﬁrst time point (2 h), the cytotoxicity of O157:H7was signiﬁcantly higher than
dose,MOI=16:1, cytotoxicity increased over time (C andD). Furthermore, at corresponding tim
cytotoxicity of K-12.4. Discussion
O157:H7 infection has become an important public health problem
threatening populations around the world (Lynch et al., 2006).
O157:H7 is highly pathogenic, and the use of antibiotic treatment can
aggravate O157:H7 infections (Bielaszewska et al., 2011). Currently,
there are no effective treatments for the disease; therefore,
preventing O157:H7 infection is particularly important. If we can
comprehensively and accurately assess the virulence of O157:H7
clinical isolates, then we can provide reliable data for clinical disease
prevention and a method for the pre-assessment of newly discov-
ered O157:H7 epidemics.HT-29 cellswere infected as described in theMaterials andMethods section. A and B show
.3:1–800:1) at 3 h post-infection, and the increasing trend of the curves is consistent with
HeLa andHT-29 cells increasedwith increasing duration of infectionwith O157:H7 and K-
that of K-12 (*, p b 0.05; **, p b 0.01; ***, p b 0.001). Meanwhile, under the ﬁxed infectious
e points, the cytotoxicity of O157:H7 to either theHeLa orHT-29 cellswas greater than the
Fig. 4. The distribution of actin inHeLa cells detected by theﬂuorescencemethod. F-actinwas detected using TRITC-conjugated phalloidin (Millipore, Billerica,MA, USA). Redﬂuorescence
on themembranes of HeLa cells indicates actin, and green ﬂuorescence on themembranes of HeLa cells indicates Vinculin. Nuclear counterstainingwas revealedwith DAPI, and all images
were overlaid.
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and still not fully understood, the consolidated results obtained from
employing different analytical methods allow a more comprehensive
understanding of the virulence of O157:H7. In the present study, we fo-
cused on the differences in the damaging effects observed between host
cells infectedwith either O157:H7 or K-12.We performed three supple-
mentary methods for assessing the overall state of the host: i) ﬂow cy-
tometry to quantitatively analyze the progress of apoptosis of infected
host cells, thus characterizing the cytotoxicity of O157:H7 to the host
cells; ii) cell vitality and LDH release analyses to quantitatively measure
the loss of cell membrane integrity of infected cells, thus characterizing
the toxicity of O157:H7 to the host cells; and iii) ﬂuorescence detection
to observe changes in the distribution of actin and the skeletal structure
of the cellmembranes of infected cells, thus characterizing the inﬂuence
of O157:H7 on the host cells in an intuitive manner.
The ﬁrst assay enables the quantitative analysis of the progression of
host cell apoptosis resulting from multiple O157:H7 virulence factors
and thus assesses virulence of O157:H7 in a comprehensive manner.
Thismethod requires a ﬂow cytometer to conduct the assay. The secondassay quantitatively analyzes the degree of damage suffered by the cell
membranes of infected host cells and is used to assess the effects of
damage to the cell membranes during infection with O157:H7. This
method can simultaneously measure multiple specimens. For the
assay, 96-, 384-, or 1536-well opaque-walled tissue culture plates can
be used. Thus, thismethod enables high-throughput sampling and anal-
yses. The third assay detects changes in cytomorphology that occur in
the host cell skeleton post-infection with O157:H7. This method, per-
formed by direct observation, can differentiate the virulence of different
bacterial strains. For the cytomorphological analysis, the readout can be
quantiﬁed through many means. It is relative quantiﬁcation. For exam-
ple, ﬂuorescence signals can be analyzed using a Leica DM4000Bmicro-
scope equipped with appropriate ﬁlters and a DFC300FX camera under
the control of LAS V4.0 software (Leica). Butwe have not done thiswork
in this study. This difference can also be observable through visual in-
spection, roughly.
The simultaneous adoption of these three supplementary methods
can be regarded as an effective supplement to the standard protocols
for testing virulence of O157:H7, due to its comprehensive, accurate,
40 X. Zhang et al. / Journal of Microbiological Methods 120 (2016) 34–40and quantitative nature. In addition, our study provides an important
reference for accurately assessing the pathogenicity of O157:H7 clinical
isolates. The methods described here have wide applicability. They can
be applied to analyze the virulence of not only O157:H7 but also other
classes of pathogenic bacteria.
Concluding remarks
The three methods can more comprehensively analyze O157:H7 cy-
totoxicity than the traditional methods, and the cytotoxicity of patho-
genic bacteria was more directly and clearly observed through them,
so they are more sensitive, accurate, and quantiﬁable method for the
systematic virulence assessment of O157:H7.
Because the composition of virulence factors of O157:H7 is very
complex and not fully understood, the comprehensive and accurate
measurement of the cytotoxicity of O157:H7 can provide a deeper un-
derstanding of virulence and be used for the pre-assessment of emerg-
ing O157:H7 outbreaks.
This study established three supplementary methods for measuring
different aspects of O157:H7-induced damage to human epithelial cell
lines. The three methods place particular emphasis on the interaction
between O157:H7 and host cells as well as the changes O157:H7 in-
duces in host cells.
The simultaneous adoption of these three methods will enable the
cytotoxicity assessment of O157:H7 and similar strains in a comprehen-
sive, accurate, and quantitative manner. These methods can also be ap-
plied to other pathogenic bacteria with cytotoxic activity to host cells.
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